References
- Leon MB, Smith CR, Mack MJ, et al. Transcatheter or surgical aortic-valve replacement in intermediate-risk patients. N Engl J Med. 2016;374:1609–1620.
- Reinöhl J, Kaier K, Reinecke H, et al. Effect of availability of transcatheter aortic-valve replacement on clinical practice. N Engl J Med. 2015;373:2438–2447.
- Villablanca PA, Mathew V, Thourani VH, et al. A meta-analysis and meta-regression of long-term outcomes of transcatheter versus surgical aortic valve replacement for severe aortic stenosis. Int J Cardiol. 2016;225:234–243.
- Holmes DR, Jr, Nishimura RA, Grover FL, et al. Annual outcomes with transcatheter valve therapy: from the STS/ACC TVT registry. Ann Thorac Surg. 2016;101:789–800.
- Chen C, Zhao ZG, Liao YB, et al. Impact of renal dysfunction on mid-term outcome after transcatheter aortic valve implantation: a systematic review and meta-analysis. PLoS One. 2015;10:e0119817.
- Mina GS, Gill P, Soliman D, et al. Diabetes mellitus is associated with increased acute kidney injury and 1-year mortality after transcatheter aortic valve replacement: a meta-analysis. Clin Cardiol. 2017;40:726–731.
- Thongprayoon C, Cheungpasitporn W, Thamcharoen N, et al. Association of frailty status with acute kidney injury and mortality after transcatheter aortic valve replacement: a systematic review and meta-analysis. PLoS One. 2017;12:e0177157.
- Tjahjadi C, Wee Y, Hay K, et al. Heyde syndrome revisited: anaemia and aortic stenosis. Intern Med J. 2017;47:814–818.
- Arai T, Morice MC, O'Connor SA, et al. Impact of pre- and post-procedural anemia on the incidence of acute kidney injury and 1-year mortality in patients undergoing transcatheter aortic valve implantation (from the French Aortic National CoreValve and Edwards 2 [FRANCE 2] Registry). Catheter Cardiovasc Interv. 2015;85:1231–1239.
- DeLarochelliere H, Urena M, Amat-Santos IJ, et al. Effect on outcomes and exercise performance of anemia in patients with aortic stenosis who underwent transcatheter aortic valve replacement. Am J Cardiol. 2015;115:472–479.
- Hellhammer K, Zeus T, Verde PE, et al. Red cell distribution width in anemic patients undergoing transcatheter aortic valve implantation. World J Cardiol. 2016;8:220–230.
- Nuis RJ, Sinning JM, Rodes-Cabau J, et al. Prevalence, factors associated with, and prognostic effects of preoperative anemia on short- and long-term mortality in patients undergoing transcatheter aortic valve implantation. Circ Cardiovasc Interv. 2013;6:625–634.
- Rheude T, Pellegrini C, Michel J, et al. Prognostic impact of anemia and iron-deficiency anemia in a contemporary cohort of patients undergoing transcatheter aortic valve implantation. Int J Cardiol. 2017;244:93–99.
- Seiffert M, Conradi L, Gutwein A, et al. Baseline anemia and its impact on midterm outcome after transcatheter aortic valve implantation. Catheter Cardiovasc Interv. 2017;89:E44–E52.
- Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010;25:603–605.
- DerSimonian R. Meta-analysis in the design and monitoring of clinical trials. Stat Med. 1996;15:1237–1248. discussion 49-52.
- Higgins JP, Thompson SG, Deeks JJ, et al. Measuring inconsistency in meta-analyses. BMJ. 2003;327:557–560.
- Ng AC, Kong WK, Kamperidis V, et al. Anaemia in patients with aortic stenosis: influence on long-term prognosis. Eur J Heart Fail. 2015;17:1042–1049.
- Migone De Amicis M, Poggiali E, Motta I, et al. Anemia in elderly hospitalized patients: prevalence and clinical impact. Intern Emerg Med. 2015;10:581–586.
- Robinson B, Artz AS, Culleton B, et al. Prevalence of anemia in the nursing home: contribution of chronic kidney disease. J Am Geriatr Soc. 2007;55:1566–1570.
- Loscalzo J. From clinical observation to mechanism-Heyde's syndrome. N Engl J Med. 2012;367:1954–1956.
- Vincentelli A, Susen S, Le Tourneau T, et al. Acquired von Willebrand syndrome in aortic stenosis. N Engl J Med. 2003;349:343–349.
- De Backer O, Arnous S, Lonborg J, et al. Recovery from anemia in patients with severe aortic stenosis undergoing transcatheter aortic valve implantation–prevalence, predictors and clinical outcome. PLoS One. 2014;9:e114038.
- Forcillo J, Condado JF, Binongo JN, et al. Readmission rates after transcatheter aortic valve replacement in high- and extreme-risk patients with severe aortic stenosis. J Thorac Cardiovasc Surg. 2017;154:445–452.
- Thongprayoon C, Cheungpasitporn W, Gillaspie EA, et al. Association of blood transfusion with acute kidney injury after transcatheter aortic valve replacement: a meta-analysis. World J Nephrol. 2016;5:482–488.
- Kleczynski P, Dziewierz A, Bagienski M, et al. Association between blood transfusions and 12-month mortality after transcatheter aortic valve implantation. Int Heart J. 2017;58:50–55.
- D'Errigo P, Biancari F, Rosato S, et al. Transcatheter aortic valve implantation compared with surgical aortic valve replacement in patients with anaemia. Acta Cardiol. 2017;73:1–10.
- Fowler AJ, Ahmad T, Phull MK, et al. Meta-analysis of the association between preoperative anaemia and mortality after surgery. Br J Surg. 2015;102:1314–1324.
- Martinsson A, Andersson C, Andell P, et al. Anemia in the general population: prevalence, clinical correlates and prognostic impact. Eur J Epidemiol. 2014;29:489–498.